Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)
Clinical trial NCT02750618 · COMPLETED
Trial details
- NCT number
- NCT02750618
- Sponsor
- Kyowa Kirin, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-05
- Primary completion
- 2017-04-20
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.